Polaris Venture Partners Founders' Fund V, L.P.'s Net Worth

$0

Estimate Recalculated Mar 28, 2025 03:22PM EST

Who is Polaris Venture Partners Founders' Fund V, L.P.?

Polaris Venture Partners Founders' Fund V, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Phreesia, Inc., BIND Therapeutics, Inc, Adagio Therapeutics, Inc., Cardlytics, Inc., Pulmatrix, Inc., OCULAR THERAPEUTIX, INC, FATE THERAPEUTICS INC, TREVENA INC, GENOCEA BIOSCIENCES, INC., SELECTA BIOSCIENCES INC, Cerulean Pharma Inc., Lyra Therapeutics, Inc., Kala Pharmaceuticals, Inc., T2 Biosystems, Inc., aTYR PHARMA INC, Arsanis, Inc., and INTERNET BRANDS, INC..

SEC CIK

Polaris Venture Partners Founders' Fund V, L.P.'s CIK is 0001439588

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Phreesia, Inc. (PHR) Snapshot price: $23.55

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-10.00%
-357.12K
$24.48
-$8,741,964.95
3.21M
Dec 17
Form 4
∞
3.57M
$18.00
-$7,142,382.00
3.57M
Jul 22
Form 3
—
0
—
—
0
No matching records found

BIND Therapeutics, Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.02M
$15.00
—
2.02M
Sep 25
Form 3
—
0
—
—
0
No matching records found

Pulmatrix, Inc. (PULM) Snapshot price: $2.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+28.53%
1.15M
—
—
5.18M
Apr 3
Form 4/A
+2.72%
74.04K
$6.88
$508,997.51
2.8M
Jun 15
Form 4
+7,856.20%
4.03M
$6.88
$9,570.00
4.08M
Jun 15
Form 3
—
0
—
—
0
No matching records found

TREVENA INC (TRVN) Snapshot price: $3.83

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.96%
-36.70K
$6.04
-$221,680.08
3.77M
Aug 14
Form 4
-0.15%
-5.70K
$6.12
-$34,884.00
3.81M
Aug 13
Form 4
∞
3.81M
$7.00
$3,306,835.00
3.81M
Feb 5
Form 3
—
0
—
—
0
No matching records found

Lyra Therapeutics, Inc. (LYRA) Snapshot price: $0.2798

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+53.22%
1.1M
$14.16
$999,969.16
3.17M
May 5
Form 3
—
0
—
—
0
No matching records found